X0607 3 2026-03-18 0 0002020932 Agomab Therapeutics NV AGMB 0002115887 Lefever Ellen true AGOMAB THERAPEUTICS NV POSTHOFLEI 1/6 ANTWERPEN C9 2600 BELGIUM 0 1 0 0 General Counsel Stock Option (Right to Buy) 2.76 2031-03-05 Common shares 91256 D Stock Option (Right to Buy) 2.76 2032-06-28 Common shares 48009 D Stock Option (Right to Buy) 2.76 2033-10-10 Common shares 54113 D Stock Option (Right to Buy) 2.76 2034-07-08 Common shares 3832 D Stock Option (Right to Buy) 3.18 2034-11-04 Common shares 132122 D Stock Option (Right to Buy) 14.26 2036-01-15 Common shares 127972 D The shares underlying this option are fully vested and exercisable. The common shares may be represented by American Depositary Shares, each of which currently represents one common share. The exercise prices are reported in U.S. dollars and reflect the conversion from EUR to USD at an exchange rate of $1.1478 per EUR 1.00 as of March 16, 2026. 50% of the shares underlying this option vested on February 9, 2026, with the remainder vesting in twenty-four equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. 25% of the shares underlying this option shall vest on February 9, 2027, with the remainder vesting in thirty-six equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. Exhibit 24 - Power of Attorney /s/ Ellen Lefever 2026-03-18